Home > Balance Sheet > BIOCON

BIOCON
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹100 Cr₹74 Cr₹81 Cr₹-241 Cr₹-275 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of BIOCON ?

The latest Deferred Tax Assets / Liabilities ratio of BIOCON is ₹100 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹100 Cr
Mar2024₹74 Cr
Mar2023₹81 Cr
Mar2022₹-241 Cr
Mar2021₹-275 Cr

How is Deferred Tax Assets / Liabilities of BIOCON Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹100 Cr
34.77
Mar2024 ₹74 Cr
-8.17
Mar2023 ₹81 Cr
Positive
Mar2022 ₹-241 Cr
Negative
Mar2021 ₹-275 Cr -

Compare Deferred Tax Assets / Liabilities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹69,466.0 Cr 2.7% 3.4% 19.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,989.0 Cr 1.7% 6.4% 12.1% Stock Analytics
DIVIS LABORATORIES ₹179,471.0 Cr 3% 2.8% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,290.0 Cr 2.3% 9.1% 44.6% Stock Analytics
CIPLA ₹117,820.0 Cr 0.3% 6.1% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹114,730.0 Cr -0.1% 8.9% 1.9% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

2.7%

3.4%

19.5%

SENSEX

0.9%

4.2%

-6%


You may also like the below Video Courses